K-One®:
redefining surface chemistry

Immobilize your ligands, not your research!

Our proprietary and patented K-One® surface chemistry is the result of over 10 years of academic research, led by Kimialys’ co-founder and Chief Scientific Officer, Dr. Claude Nogues, at Paris-Saclay University. K-One® unlocks applications that were previously out of reach due to technological limitations and sets a new standard for surface treatment in Life Science, especially for biomolecule detection and characterization.

The Genesis of K-One®

A breakthrough born from a need to overcome the limits of existing surface chemistries.

While surface chemistries are essential for biosensing applications, very little innovation has occurred in this field since the 1990s, when Self-Assembled Monolayers (SAMs), coatings only a few nanometers thick, were introduced. Kimialys’ patented chemistry was first developed in the early 2010s by our co-founder and Chief Scientific Officer, Dr. Claude Nogues, and her team while studying gene expression in cell extracts, a highly complex biological medium, using gold SPR sensor chips. Their primary goal was to eliminate non-specific bindings that existing coatings could not prevent. After successful initial experiments, the coating was refined over more than a decade across a wide range of use cases to become our current K-One® technology, the most effective gold surface functionalization to date for challenging biomolecule detection and characterization.

K-One® technology platform

In our context, ligands refer to biomolecules immobilized on biosensing surfaces such as nanoparticles, chips, or electrodes. These surfaces possess optical or electrical properties that enable the detection of a target once it is captured by the ligand.Without a properly optimized surface chemistry, ligand immobilization becomes uncontrolled, leading to random and variable attachment to the sensor surface. Mastering ligand immobilization is crucial, as it directly impacts key performance parameters such as sensitivity, specificity, and reproducibility in diagnostics and other in vitro assays.

Figure: conventional vs. K-One® -bases controlled ligand immobilization

Figure 1 - Ligands bind in an uncontrolled or even random fashion to the surface of gold nanoparticles or chips, resulting in only 20-30% of the ligands being available to interact with their target.
Figure 2 - The K-One® technology allows to control the ligands' exposure, density, and distribution, resulting in more than 90% of the ligands being available to interact with their target, while protecting the reaming part of the surface against undesired interactions.

Applications

In a nutshell, this is what K-One® brings to the table:    

  • High versatility: supports a wide range of biomolecules, biosensing platforms, bioconjugation strategies, biological media, and applications.
  • Optimal ligand functionality: control over ligand exposure, density, and distribution, resulting in more than 90% of ligands being functional.
  • Flawless surface protection: drastic reduction of non-specific binding.
  • Outperforming traditional conjugation strategies: covalent binding approach, removing the need for affinity-based systems (e.g., streptavidin/biotin) while remaining compatible with them.
  • Enhancing key assay performance parameters: optimal sensitivity, selectivity, specificity, and reproducibility without compromising one parameter for another.
  • Cost-effective: no need to saturate the surface for every application, leading to significant savings in ligand consumption. 
  • Enables novel applications


P.S.
K-One® has been successfully implemented on gold surfaces. If you're interested in applying our surface chemistry to another material, we’d be glad to explore a co-development to adapt and optimize the chemistry for that material.

P.P.S. Our K-One® surface chemistry is also available for licensing, offering the opportunity to integrate it directly into your production workflows and quality standards.

You know the basics about K-One®, it’s time to explore our solutions!

FAQ

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique.

How do you optimize antibody pairing for LFA development?
  • Pre-functionalization of SPR sensor chips using K-One® surface chemistry, specifically customized to your applications

  • Optimal ligand immobilization following Kimialys' proprietary protocol

  • In-house biomolecular interaction analysis with our own SPRi/SPR platforms

  • Reliable access to binding and kinetics data, complemented by high-quality reports and presentations, offering actionable insights

Binding interactions screening and epitope binning

We harness both our expertise in SPRi and proprietary K-One® technology on chip to swiftly identify and rank both desired and undesired binding interactions among numerous candidates. This ensures our customers receive consistent and reliable results, accelerating their pursuit of new therapeutics.

We can immobilize any ligands:

  • Antibodies

  • Nanobodies

  • Small molecules

  • Proteins

  • DNA/RNA

  • Whole cells

  • Peptides

  • Aptamers

  • And more...

Our results are consistent and reliable for any complex biological matrices:

  • Plasma

  • Serum

  • Blood

  • Stem cell supernatant

  • Hybridoma supernatant

  • And more...

Kinetics characterization

Reliable measurement of kinetic constants is pivotal for the development of new therapeutics. Leveraging our proprietary K-One® technology, we stand out in the SPR landscape by delivering precise characterization analysis for all biologics and compounds.

Kinetics measured:

  • Affinity (KD)

  • Binding rate constants (kon, koff)

  • Avidity

How do you optimize antibody for LFA development?
  • Pre-functionalization of SPR sensor chips using K-One® surface chemistry, specifically customized to your applications

  • Optimal ligand immobilization following Kimialys' proprietary protocol

  • In-house biomolecular interaction analysis with our own SPRi/SPR platforms

  • Reliable access to binding and kinetics data, complemented by high-quality reports and presentations, offering actionable insights

Binding interactions screening and epitope binning

We harness both our expertise in SPRi and proprietary K-One® technology on chip to swiftly identify and rank both desired and undesired binding interactions among numerous candidates. This ensures our customers receive consistent and reliable results, accelerating their pursuit of new therapeutics.

We can immobilize any ligands:

  • Antibodies

  • Nanobodies

  • Small molecules

  • Proteins

  • DNA/RNA

  • Whole cells

  • Peptides

  • Aptamers

  • And more...

Our results are consistent and reliable for any complex biological matrices:

  • Plasma

  • Serum

  • Blood

  • Stem cell supernatant

  • Hybridoma supernatant

  • And more...

Kinetics characterization

Reliable measurement of kinetic constants is pivotal for the development of new therapeutics. Leveraging our proprietary K-One® technology, we stand out in the SPR landscape by delivering precise characterization analysis for all biologics and compounds.

Kinetics measured:

  • Affinity (KD)

  • Binding rate constants (kon, koff)

  • Avidity

How do you optimize antibody pairing for LFA development?
  • Pre-functionalization of SPR sensor chips using K-One® surface chemistry, specifically customized to your applications

  • Optimal ligand immobilization following Kimialys' proprietary protocol

  • In-house biomolecular interaction analysis with our own SPRi/SPR platforms

  • Reliable access to binding and kinetics data, complemented by high-quality reports and presentations, offering actionable insights

Binding interactions screening and epitope binning

We harness both our expertise in SPRi and proprietary K-One® technology on chip to swiftly identify and rank both desired and undesired binding interactions among numerous candidates. This ensures our customers receive consistent and reliable results, accelerating their pursuit of new therapeutics.

We can immobilize any ligands:

  • Antibodies

  • Nanobodies

  • Small molecules

  • Proteins

  • DNA/RNA

  • Whole cells

  • Peptides

  • Aptamers

  • And more...

Our results are consistent and reliable for any complex biological matrices:

  • Plasma

  • Serum

  • Blood

  • Stem cell supernatant

  • Hybridoma supernatant

  • And more...

Kinetics characterization

Reliable measurement of kinetic constants is pivotal for the development of new therapeutics. Leveraging our proprietary K-One® technology, we stand out in the SPR landscape by delivering precise characterization analysis for all biologics and compounds.

Kinetics measured:

  • Affinity (KD)

  • Binding rate constants (kon, koff)

  • Avidity

What factors impact the accuracy of an LFA test?
  • Pre-functionalization of sensor chips using K-One® surface chemistry, specifically customized to your applications and analytical platforms

  • Supply of batches of pre-functionalized sensor chips + ligand immobilization protocol and reagent

Our pre-functionalization technology is compatible with all gold-based sensors.

For companies looking to manage their own analyses, yet eager to leverage our expertise in chip functionalization and our proficiency in tackling complex analytical challenges.

We provide custom pre-functionalized sensor chips, specifically designed for your ligands, analytical platform, and applications, ensuring that your analyses run smoothly and effectively.

Gold-based sensor types:

  • For common SPR and SPRi platforms: Biacore, Horiba...

  • Other SPR-based biosensors: LSPR, Fiber Optic SPR, LR-SPR...

  • For chip-based diagnostic applications: electrochemical biosensors, QCM...

K-One® technology licensing

Our K-One® surface chemistry technology is available for licensing, offering the opportunity to integrate it within your own production environment and standards.

Still have a question ?

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique.

Contact us